Lanzamiento Enero 2027

Ensayo controlado aleatorizado2008Financiación no declarada

Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil

Killgore WD, Grugle NL, Killgore DB, Leavitt BP, Watlington GI, McNair S, Balkin TJ

Aviation, space, and environmental medicine · 34 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2008-09-01 · Aviat Space Environ Med · vol. 79 · número 9 · págs. 867–874
Editorial
Aerospace Medical Association
Citado
68 citas · más que el 94% de estudios similares · 5.2× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
0 trabajos
Acceso
De pago
Áreas de investigación
Sleep and Work-Related Fatigue · Sleep and Wakefulness Research · Coffee research and impacts
Palabras clave
sleep deprivation, risk propensity, d-amphetamine, modafinil, caffeine, stimulant medication, cognitive performance, decision-making, risk judgment, sensation seeking, cognitive ability
MeSH
humans, sleep deprivation, dextroamphetamine, benzhydryl compounds, caffeine, central nervous system stimulants, risk, risk-taking, cognition, decision making, judgment, intelligence tests, psychometrics, adult, female, male, modafinil

7 autores

  • William D. S. Killgore🇺🇸Harvard University; McLean Hospital
  • Nancy L. Grugle🇺🇸Walter Reed Army Institute of Research
  • Desiree B. Killgore🇺🇸Walter Reed Army Institute of Research
  • Brian P. Leavitt🇺🇸Walter Reed Army Institute of Research
  • George I. Watlington🇺🇸Walter Reed Army Institute of Research
  • Shanelle McNair🇺🇸Walter Reed Army Institute of Research
  • Thomas J. Balkin🇺🇸Walter Reed Army Institute of Research

Resumen

El texto original del estudio, en el idioma en que se publicó.

Introduction

Sleep deprivation alters risk-related judgments, decision-making, and behavioral control. Stimulant medications are used to restore cognitive performance, but their effects on risk-taking and judgment in sleep-deprived subjects have not been explored.

Methods

There were 54 healthy adults (29 men, 25 women; age range 18 to 36) who completed a test of cognitive ability and daily measures of risk-taking propensity, including the Brief Sensation Seeking Scale (BSSS), Evaluation of Risks (EVAR) scale, and the Balloon Analog RiskTask (BART). Following 44 h of continuous wakefulness, participants ingested caffeine 600 mg (N = 12), dextroamphetamine 20 mg (N = 16), modafinil 400 mg (N = 12), or a placebo (N = 14) in a double blind manner, and completed risk-taking measures 2 h later (i.e., 0535).

Results

Relative to rested baseline, the placebo group showed a decline in risk-taking as measured by the BSSS (16% decline), EVAR Danger Seeking (32% decline) and Energy (22% decline), and BART (32% decline), consistent with previous reports of the effects of sleep deprivation. Comparisons among drug conditions showed that dextroamphetamine restored risk-taking propensity and risky behavior to baseline levels, an effect that was significantly greater than placebo or caffeine for several indices of risk-taking, but which did not differ from modafinil. Cognitive ability was significantly correlated with changes on some risk-taking indices following stimulant administration.

Conclusions

Stimulant medications, particularly dextroamphetamine, sustained risk-related attitudes and behavior during continuous wakefulness. The extent to which stimulants restore other aspects of judgment during sleep loss remains to be determined.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.